The functional delineation of the India Ultrasound Gastroscopes Market segment is primarily driven by the procedural classification, namely diagnostic and therapeutic (or interventional) Endoscopic Ultrasound (EUS). The diagnostic segment holds a substantial market share and is the foundational pillar of EUS usage, involving the high-resolution imaging used for the staging of gastrointestinal, esophageal, and lung cancers, as well as the detailed evaluation of chronic pancreatitis and submucosal lesions. The increasing incidence of these non-communicable diseases across India ensures a steady and growing demand for diagnostic EUS, which provides superior localized imaging compared to traditional CT or MRI scans.

However, the therapeutic (interventional) India Ultrasound Gastroscopes Market segment is projected to exhibit faster growth, driven by the shift towards minimally invasive procedures. This segment includes complex, EUS-guided procedures such as Fine Needle Aspiration (FNA) for tissue sampling, celiac plexus neurolysis for pain management in pancreatic cancer patients, and the drainage of pancreatic pseudocysts or abscesses. These interventions, which offer less patient trauma and faster recovery times than open surgery, are becoming increasingly common in specialized Indian centers. The growing proficiency of local endosonographers in these advanced techniques, supported by manufacturer-led training programs, is the core factor accelerating the growth of the interventional EUS segment, significantly boosting the demand for therapeutic-grade ultrasound gastroscopes